Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, June 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 188 articles:
HTML format


 

Single Articles

  1. CHATTERJEE K, Mukherjee S, Vanmanen J, Banerjee P, et al
    Dietary Polyphenols, Resveratrol and Pterostilbene Exhibit Antitumor Activity on an HPV E6-Positive Cervical Cancer Model: An in vitro and in vivo Analysis.
    Front Oncol. 2019;9:352.
    Abstract    

    Abstract available

  2. ALAS QMDA, Lin CT
    Immunotherapy with Subcutaneous Injection of Immunomodulatory Agent (OK-432) Elicits Durable Response in Locally Advanced or Relapsed Cervical Cancer.
    Gynecol Minim Invasive Ther. 2019;8:80-82.
    Abstract    

    Abstract available

  3. LIM TYK, Lin KKM, Wong WL, Aggarwal IM, et al
    Surgical and Oncological Outcome of Total Laparoscopic Radical Hysterectomy versus Radical Abdominal Hysterectomy in Early Cervical Cancer in Singapore.
    Gynecol Minim Invasive Ther. 2019;8:53-58.
    Abstract    

    Abstract available

  4. MIAO H, Wang N, Shi LX, Wang Z, et al
    Overexpression of mircoRNA-137 inhibits cervical cancer cell invasion, migration and epithelial-mesenchymal transition by suppressing the TGF-beta/smad pathway via binding to GREM1.
    Cancer Cell Int. 2019;19:147.
    Abstract    

    Abstract available

  5. GU X, Dong M, Liu Z, Mi Y, et al
    Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer.
    Cancer Cell Int. 2019;19:146.
    Abstract    

    Abstract available

  6. GUPTA S
    Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken.
    J Gynecol Oncol. 2019;30:e97.
    Abstract    



  7. AHN K, Kweon S, Kim DW, Lee H, et al
    Different expression of GSK3beta and pS9GSK3beta depending on phenotype of cervical cancer: possible association of GSK3beta with squamous cell carcinoma and pS9GSK3beta with adenocarcinoma.
    Obstet Gynecol Sci. 2019;62:157-165.
    Abstract    

    Abstract available

  8. MATSUKAWA H, Sasaki T, Hirayama R, Hirose TA, et al
    Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer.
    J Contemp Brachytherapy. 2019;11:137-145.
    Abstract    

    Abstract available

  9. CARVALHO J, Paiva A, Cabral Campello MP, Paulo A, et al
    Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
    Sci Rep. 2019;9:7945.
    Abstract    

    Abstract available

  10. LEE S, Ho JY, Liu JJ, Lee H, et al
    CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
    Mol Med. 2019;25:23.
    Abstract    

    Abstract available

  11. WANG M, Xue Y, Shen L, Qin P, et al
    Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.
    Redox Biol. 2019;24:101225.
    Abstract    

    Abstract available

  12. SAWAYA GF, Smith-McCune K, Kuppermann M
    Cervical Cancer Screening: More Choices in 2019.
    JAMA. 2019;321:2018-2019.
    Abstract    



  13. PERKINS RB, Austin RM, Zhao C, Saslow D, et al
    What Role Should Cytology Play in Cervical Cancer Screening?
    J Low Genit Tract Dis. 2019 May 21. doi: 10.1097/LGT.0000000000000479.
    Abstract    



  14. LEE SI, Atri M
    2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-Sectional Imaging.
    Radiology. 2019 May 28:190088. doi: 10.1148/radiol.2019190088.
    Abstract    

    Abstract available

  15. MESSOUDI W, Elmahi T, Nejjari C, Tachfouti N, et al
    Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.
    J Med Econ. 2019 May 28:1. doi: 10.1080/13696998.2019.1624556.
    Abstract    

    Abstract available

  16. SHEN WC, Chen SW, Wu KC, Hsieh TC, et al
    Prediction of local relapse and distant metastasis in patients with definitive chemoradiotherapy-treated cervical cancer by deep learning from [(18)F]-fluorodeoxyglucose positron emission tomography/computed tomography.
    Eur Radiol. 2019 May 27. pii: 10.1007/s00330-019-06265.
    Abstract    

    Abstract available

  17. SHAFABAKHSH R, Reiter RJ, Mirzaei H, Teymoordash SN, et al
    Melatonin: A new inhibitor agent for cervical cancer treatment.
    J Cell Physiol. 2019 May 27. doi: 10.1002/jcp.28865.
    Abstract    

    Abstract available

  18. WEBB K, Prakash V, Kirresh O, Stewart A, et al
    A case of aortitis during cisplatin-based chemotherapy for cervical cancer.
    BJR Case Rep. 2018;5:20180054.
    Abstract    

    Abstract available

  19. TSUI J, Llanos AA, Doose M, Rotter D, et al
    Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.
    J Health Care Poor Underserved. 2019;30:680-701.
    Abstract    

    Abstract available

  20. LEE F, Paszat LF, Sutradhar R
    Immigration and Adherence to Cervical Cancer Screening: A Provincewide Longitudinal Matched Cohort Study Using Multistate Transitional Models.
    J Obstet Gynaecol Can. 2019;41:813-823.
    Abstract    

    Abstract available

  21. MAGUIRE PJ, Sobota A, Mulholland D, Ryan JM, et al
    Incidence, management, and sequelae of ureteric obstruction in women with cervical cancer.
    Support Care Cancer. 2019 May 25. pii: 10.1007/s00520-019-04851.
    Abstract    

    Abstract available

  22. PAPATLA K, Halpern MT, Hernandez E, Brown J, et al
    Second primary anal and oropharyngeal cancers in cervical cancer survivors.
    Am J Obstet Gynecol. 2019 May 22. pii: S0002-9378(19)30683.
    Abstract    

    Abstract available

  23. GRANADOS-GARCIA V, Pina-Sanchez P, Reynoso-Noveron N, Flores YN, et al
    Medical Cost to Treat Cervical Cancer Patients at a Social Security Third Level Oncology Hospital in Mexico City
    Asian Pac J Cancer Prev. 2019;20:1547-1554.
    Abstract    

    Abstract available

  24. HUA F, Li CH, Gao YC, Li J, et al
    Molecular mechanism and role of NF-kappaB in the early diagnosis of cervical cancer.
    J BUON. 2019;24:720-728.
    Abstract    

    Abstract available

  25. KHALKHALI HR, Gharaaghaji R, Valizadeh R, Kousehlou Z, et al
    Ten Years' Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model
    Asian Pac J Cancer Prev. 2019;20:1345-1351.
    Abstract    

    Abstract available

  26. ROJO-LEON V, Garcia C, Valencia C, Mendez MA, et al
    The E6/E7 oncogenes of human papilloma virus and estradiol regulate hedgehog signaling activity in a murine model of cervical cancer.
    Exp Cell Res. 2019 May 21. pii: S0014-4827(19)30265.
    Abstract    

    Abstract available

  27. MENG Y, Liu YL, Li K, Fu T, et al
    Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
    Medicine (Baltimore). 2019;98:e15793.
    Abstract    

    Abstract available

  28. ZHAO H, He Y, Zhu LR, Wang JL, et al
    Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
    Medicine (Baltimore). 2019;98:e15604.
    Abstract    

    Abstract available

  29. YAMAZAKI H, Nakamura T, Otsuki Y, Tuchiya M, et al
    Sudden fatal bleeding from a uretero-arterial fistula combined with pre-existing uretero-colic and uretero-vaginal fistulas 7 years after a cervical cancer surgery: a case report.
    Surg Case Rep. 2019;5:85.
    Abstract    

    Abstract available

  30. JAVAEED A, Shoukat S, Hina S, Hameed Z, et al
    Knowledge, Attitude, and Practices Related to Cervical Cancer Among Adult Women in Azad Kashmir: A Hospital-based Cross-sectional Study.
    Cureus. 2019;11:e4234.
    Abstract    

    Abstract available

  31. YAN DD, Tang Q, Tu YQ, Chen JH, et al
    A comprehensive analysis of the factors of positive pelvic lymph nodes on survival of cervical cancer patients with 2018 FIGO stage IIIC1p.
    Cancer Manag Res. 2019;11:4223-4230.
    Abstract    

    Abstract available

  32. WANG W, Liu X, Meng Q, Zhang F, et al
    Comparisons of survivals and toxicities between young and elderly patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy.
    Taiwan J Obstet Gynecol. 2019;58:364-369.
    Abstract    

    Abstract available

  33. VAHEDPOOR Z, Behrashi M, Khamehchian T, Abedzadeh-Kalahroudi M, et al
    Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening.
    Taiwan J Obstet Gynecol. 2019;58:345-348.
    Abstract    

    Abstract available

  34. PAPOUTSIS D
    An appraisal of the meta-analysis on the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions.
    Prev Med. 2019;123:341-342.
    Abstract    



  35. WHITE IM, Scurr E, Wetscherek A, Brown G, et al
    Realising the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer.
    Br J Radiol. 2019 Apr 1:20180670. doi: 10.1259/bjr.20180670.
    Abstract    

    Abstract available

  36. SKOULAKIS A, Fountas S, Mantzana-Peteinelli M, Pantelidi K, et al
    Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review.
    BMC Infect Dis. 2019;19:192.
    Abstract    

    Abstract available

  37. KIWERSKA K, Jozefiak A, Markowska J, Kedzia W, et al
    Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42.
    BMC Infect Dis. 2019;19:122.
    Abstract    

    Abstract available

  38. CLEMENTE-SOTO AF, Salas-Vidal E, Milan-Pacheco C, Sanchez-Carranza JN, et al
    Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expressionindependent manner in HPVpositive human cervical cancerderived cells.
    Mol Med Rep. 2019;19:2097-2106.
    Abstract    

    Abstract available

  39. S R, M P
    Multi-functional core-shell Fe3O4@Au nanoparticles for cancer diagnosis and therapy.
    Colloids Surf B Biointerfaces. 2019;174:252-259.
    Abstract    

    Abstract available

  40. NAGASE S, Ohta T, Takahashi F, Enomoto T, et al
    Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010.
    J Obstet Gynaecol Res. 2019;45:289-298.
    Abstract    

    Abstract available

  41. KOBAYASHI Y, Tabata T, Omori M, Kondo E, et al
    A Japanese survey of malignant disease in pregnancy.
    Int J Clin Oncol. 2019;24:328-333.
    Abstract    

    Abstract available

  42. MATSUURA H, Arase S, Hori Y
    Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Int J Clin Oncol. 2019;24:306-312.
    Abstract    

    Abstract available

  43. MCCUNE KC, Imborek KL
    Clinical Care of Lesbian and Bisexual Women for the Obstetrician Gynecologist.
    Clin Obstet Gynecol. 2018 Oct 3. doi: 10.1097/GRF.0000000000000399.
    Abstract    

    Abstract available

  44. HOYOS FT, Martin-Landrove M, Navarro RB, Villadiego JV, et al
    Study of cervical cancer through fractals and a method of clustering based on quantum mechanics.
    Appl Radiat Isot. 2019;150:182-191.
    Abstract    

    Abstract available

  45. YU L, Sabatino SA, White MC
    Rural-Urban and Racial/Ethnic Disparities in Invasive Cervical Cancer Incidence in the United States, 2010-2014.
    Prev Chronic Dis. 2019;16:E70.
    Abstract    

    Abstract available

  46. KEDHARI SUNDARAM M, Hussain A, Haque S, Raina R, et al
    Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
    J Cell Biochem. 2019 Jun 6. doi: 10.1002/jcb.29147.
    Abstract    

    Abstract available

  47. ABOREHAB NM, Osama N
    Effect of Gallic acid in potentiating chemotherapeutic effect of Paclitaxel in HeLa cervical cancer cells.
    Cancer Cell Int. 2019;19:154.
    Abstract    

    Abstract available

  48. SABULEI C, Maree JE
    An exploration into the quality of life of women treated for cervical cancer.
    Curationis. 2019;42:e1-e9.
    Abstract    

    Abstract available

  49. CARTER J
    Safety of laparoscopy in cervical cancer.
    Aust N Z J Obstet Gynaecol. 2019;59:E9.
    Abstract    



  50. ZHAO H, Zheng GH, Li GC, Xin L, et al
    Long noncoding RNA LINC00958 regulates cell sensitivity to radiotherapy through RRM2 by binding to microRNA-5095 in cervical cancer.
    J Cell Physiol. 2019 Jun 6. doi: 10.1002/jcp.28902.
    Abstract    

    Abstract available

  51. HU R, Zhu Z
    ELK1-activated GPC3-AS1/GPC3 axis promotes the proliferation and migration of cervical cancer cells.
    J Gene Med. 2019 Jun 6:e3099. doi: 10.1002/jgm.3099.
    Abstract    

    Abstract available

  52. CHOPRA S, Shukla R, Budukh A, Shrivastava SK, et al
    External Radiation and Brachytherapy Resource Deficit for Cervical Cancer in India: Call to Action for Treatment of All.
    J Glob Oncol. 2019;5:1-5.
    Abstract    



  53. BALANDA M, Fernandez J, Vergara N, Campano C, et al
    Genetic variability of human papillomavirus type 66 L1 gene among women presenting for cervical cancer screening in Chile.
    Med Microbiol Immunol. 2019 Jun 4. pii: 10.1007/s00430-019-00621.
    Abstract    

    Abstract available

  54. CREZEE H, Kok HP, Oei AL, Franken NAP, et al
    The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer.
    Front Oncol. 2019;9:412.
    Abstract    



  55. JIANG H, Liang M, Jiang Y, Zhang T, et al
    The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer.
    Cancer Cell Int. 2019;19:152.
    Abstract    

    Abstract available

  56. LIU F, Zou Y, Wang F, Yang B, et al
    FBXW7 Mutations Promote Cell Proliferation, Migration, and Invasion in Cervical Cancer.
    Genet Test Mol Biomarkers. 2019;23:409-417.
    Abstract    

    Abstract available

  57. MENDEZ LC, Moraes FY, Castilho MS, Louie AV, et al
    Lives and Economic Loss in Brazil due to Lack of Radiotherapy Access in Cervical Cancer: A Cost-Effectiveness Analysis.
    Clin Oncol (R Coll Radiol). 2019 May 31. pii: S0936-6555(19)30196.
    Abstract    

    Abstract available

  58. MARKOWITZ LE, Naleway AL, Lewis RM, Crane B, et al
    Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
    Vaccine. 2019 May 31. pii: S0264-410X(19)30626.
    Abstract    

    Abstract available

  59. NATIONAL HEALTH COMMISSION OF
    Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version).
    Chin J Cancer Res. 2019;31:295-305.
    Abstract    



  60. DA MOTA ALMEIDA PERONI F, Lindelow M, Oliveira De Souza D, Sjoblom M, et al
    Realizing the right to health in Brazil's Unified Health System through the lens of breast and cervical cancer.
    Int J Equity Health. 2019;18:39.
    Abstract    

    Abstract available

  61. TAKEUCHI M, Matsuzaki K, Bando Y, Harada M, et al
    Reduced field-of-view diffusion-weighted MR imaging for assessing the local extent of uterine cervical cancer.
    Acta Radiol. 2019 Jun 1:284185119852733. doi: 10.1177/0284185119852733.
    Abstract    

    Abstract available

  62. ZHAO Y, Liao Q, Mi X, Li MZ, et al
    [Survey of the acceptance status of HPV self-sampling screening in female population for cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:312-317.
    Abstract    

    Abstract available

  63. CHEN Q, Du H, Wang C, Hu QC, et al
    [Value of the BioPerfectus multiplex real time HPV assay for self-collected samples cervical cancer screening].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:307-311.
    Abstract    

    Abstract available

  64. WANG JJ, Dong J, Deng ZX, Wang PF, et al
    [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:301-306.
    Abstract    

    Abstract available

  65. WANG WP, An JS, Yao HW, Li N, et al
    [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:293-300.
    Abstract    

    Abstract available

  66. WEI LH
    [Cervical cancer screning: from cytology to HPV testing].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:289-292.
    Abstract    



  67. PAUL P, Koh WP, Jin A, Michel A, et al
    Soy and tea intake on cervical cancer risk: the Singapore Chinese Health Study.
    Cancer Causes Control. 2019 Jun 1. pii: 10.1007/s10552-019-01173.
    Abstract    

    Abstract available

  68. HUYNH-LE MP, Klapheke A, Cress R, Mell LK, et al
    Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Brachytherapy. 2019 May 29. pii: S1538-4721(18)30761.
    Abstract    

    Abstract available

  69. HSIAO YH, Hsieh MJ, Yang SF, Chen SP, et al
    Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
    Phytomedicine. 2019;62:152964.
    Abstract    

    Abstract available

  70. RODIN D, Burger EA, Atun R, Barton M, et al
    Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
    Lancet Oncol. 2019 May 28. pii: S1470-2045(19)30308.
    Abstract    

    Abstract available

  71. MAHANTSHETTY UM
    Scale-up of radiotherapy for cervical cancer.
    Lancet Oncol. 2019 May 28. pii: S1470-2045(19)30376.
    Abstract    



  72. VITKAUSKAITE A, Celiesiute J, Paskauskas S, Skrodeniene E, et al
    Associations among Serum Lipocalin-2 Concentration, Human Papilloma Virus and Clinical Stage of Cervical Cancer.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  73. ZHAO J, Lee EE, Kim J, Yang R, et al
    Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus.
    Nat Commun. 2019;10:2300.
    Abstract    

    Abstract available

  74. THAY S, Peprah SA, Hur C, Tramontano AC, et al
    Prevalence of Cervical Dysplasia in HIV-Positive and HIV-Negative Women at the Sihanouk Hospital Center of HOPE, Phnom Penh , Cambodia
    Asian Pac J Cancer Prev. 2019;20:653-659.
    Abstract    

    Abstract available

  75. BUDAK A, Kanmaz AG
    Role of endometrial sampling in cases with asymptomatic cervical polyps.
    J Gynecol Obstet Hum Reprod. 2019;48:207-211.
    Abstract    

    Abstract available

  76. WU N, Zhao Z, Han D, Cheng G, et al
    Dosimetric research into target regions and organs at risk in three-dimensional intracavitary brachytherapy techniques for Chinese patients with cervical carcinoma.
    J Radiat Res. 2019;60:124-133.
    Abstract    

    Abstract available

  77. VALLAPAPAN A, Chandeying N, Srijaipracharoen S, Uthagethaworn K, et al
    The role of random cervical biopsies in addition to colposcopy-directed biopsies in detection of CIN2.
    J Obstet Gynaecol. 2019;39:184-189.
    Abstract    

    Abstract available

  78. ZHANG JJ, Fan LP
    Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression.
    Biomed Pharmacother. 2019;117:108726.
    Abstract    

    Abstract available

  79. GUTIERREZ-HOYA A, Zerecero-Carreon O, Valle-Mendiola A, Moreno-Lafont M, et al
    Cervical Cancer Cells Express Markers Associated with Immunosurveillance.
    J Immunol Res. 2019;2019:1242979.
    Abstract    

    Abstract available

  80. KHANNA D, Khargekar N, Budukh A
    Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India.
    J Family Med Prim Care. 2019;8:1715-1719.
    Abstract    

    Abstract available

  81. MANIKANDAN S, Behera S, Naidu NM, Angamuthu V, et al
    Knowledge and Awareness Toward Cervical Cancer Screening and Prevention Among the Professional College Female Students.
    J Pharm Bioallied Sci. 2019;11.
    Abstract    

    Abstract available

  82. ANDREASSEN T, Melnic A, Figueiredo R, Moen K, et al
    Correction to: Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania.
    Int J Public Health. 2019 Jun 14. pii: 10.1007/s00038-019-01263.
    Abstract    

    Abstract available

  83. OKETCH SY, Kwena Z, Choi Y, Adewumi K, et al
    Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    BMC Womens Health. 2019;19:75.
    Abstract    

    Abstract available

  84. WANG N, Wang J, Meng X, Li T, et al
    The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA.
    Mol Ther Oncolytics. 2019;14:121-129.
    Abstract    

    Abstract available

  85. KIM HW, Lee YJ, Lee DB, Lee EJ, et al
    Effects of cervical cancer prevention education in middle-school girls in Korea: A mixed-method study.
    Heliyon. 2019;5:e01826.
    Abstract    

    Abstract available

  86. GUO Q, Cai S, Qian J, Tian Y, et al
    Dose optimization strategy of sacrum limitation in cervical cancer intensity modulation radiation therapy planning.
    Medicine (Baltimore). 2019;98:e15938.
    Abstract    

    Abstract available

  87. MA L, Cheng Y, Zeng J
    MLK3 silence induces cervical cancer cell apoptosis via the Notch-1/autophagy network.
    Clin Exp Pharmacol Physiol. 2019 Jun 13. doi: 10.1111/1440-1681.13123.
    Abstract    

    Abstract available

  88. GAO R, Wu X, Huang Z, Wang B, et al
    Anti-tumor effect of aloe-emodin on cervical cancer cells was associated with human papillomavirus E6/E7 and glucose metabolism.
    Onco Targets Ther. 2019;12:3713-3721.
    Abstract    

    Abstract available

  89. SUN H, Fan G, Deng C, Wu L, et al
    miR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51.
    J Cell Physiol. 2019 Jun 12. doi: 10.1002/jcp.28957.
    Abstract    

    Abstract available

  90. LEVI JE, Martins TR, Longatto-Filho A, Cohen DD, et al
    HIGH-RISK HPV TESTING IN PRIMARY SCREENING FOR CERVICAL CANCER IN THE PUBLIC HEALTH SYSTEM, SAO PAULO, BRAZIL.
    Cancer Prev Res (Phila). 2019 Jun 12. pii: 1940-6207.CAPR-19-0076.
    Abstract    

    Abstract available

  91. NYENGIDIKI TK, Inimgba N, Bassey G, Ogu RN, et al
    Does introduction of user fees affect the utilization of cervical cancer screening services in Nigeria?
    Niger J Clin Pract. 2019;22:745-749.
    Abstract    

    Abstract available

  92. TROGDON JG, Ekwueme DU, Subramanian S, Miller JW, et al
    The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Cancer Causes Control. 2019 Jun 11. pii: 10.1007/s10552-019-01190.
    Abstract    

    Abstract available

  93. JIANG J, Li X, Yin X, Zhang J, et al
    Association of low expression of E-cadherin and beta-catenin with the progression of early stage human squamous cervical cancer.
    Oncol Lett. 2019;17:5729-5739.
    Abstract    

    Abstract available

  94. YANG D, Zhang Q
    miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer.
    Oncol Lett. 2019;17:5693-5698.
    Abstract    

    Abstract available

  95. CHOKCHAICHAMNANKIT D, Watcharatanyatip K, Subhasitanont P, Weeraphan C, et al
    Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis.
    Oncol Lett. 2019;17:5453-5468.
    Abstract    

    Abstract available

  96. ZHANG Y, Yan Y, Yang Y
    Study on value of ultrasonic elastography in diagnosis of clinical staging of cervical cancer and efficacy evaluation of radiotherapy.
    Oncol Lett. 2019;17:4901-4906.
    Abstract    

    Abstract available


  97. Aiming TILs at Melanoma, Cervical Cancer.
    Cancer Discov. 2019 Jun 11. pii: 2159-8290.CD-NB2019.
    Abstract    

    Abstract available

  98. LIU GD, Liang GQ, Wang H, Zhou Y, et al
    Effect of general anesthesia combined with epidural anesthesia on perioperative immune factors in cervical cancer.
    J Biol Regul Homeost Agents. 2019;33.
    Abstract    

    Abstract available

  99. XUE Y, Zhao Y, Yao L, Li W, et al
    [Development of Diffuse Reflectance Spectroscopy Detection and Analysis System for Cervical Cancer].
    Zhongguo Yi Liao Qi Xie Za Zhi. 2019;43:157-161.
    Abstract    

    Abstract available

  100. LOZARES-CORDERO S, Font-Gomez JA, Gandia-Martinez A, Miranda-Burgos A, et al
    Treatment of cervical cancer with electronic brachytherapy.
    J Appl Clin Med Phys. 2019 Jun 11. doi: 10.1002/acm2.12657.
    Abstract    

    Abstract available

  101. YIN L, Lu S, Zhu J, Zhang W, et al
    Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint.
    Radiat Oncol. 2019;14:100.
    Abstract    

    Abstract available

  102. MAO BD, Xu P, Xu P, Zhong Y, et al
    LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
    J Biosci. 2019;44.
    Abstract    

    Abstract available

  103. LYU X, Jiang Y, Zhang M, Li G, et al
    Genomic stratification based on radiosensitivity and PD-L1 for tailoring therapeutic strategies in cervical cancer.
    Epigenomics. 2019 Jun 10. doi: 10.2217/epi-2019-0108.
    Abstract    

    Abstract available

  104. O'DONOVAN J, O'Donovan C, Nagraj S
    The role of community health workers in cervical cancer screening in low-income and middle-income countries: a systematic scoping review of the literature.
    BMJ Glob Health. 2019;4:e001452.
    Abstract    

    Abstract available

  105. CEZAR-DOS-SANTOS F, Ferreira RS, Okuyama NCM, Trugilo KP, et al
    FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.
    J Cancer Res Clin Oncol. 2019 Jun 8. pii: 10.1007/s00432-019-02951.
    Abstract    

    Abstract available

  106. GOSSET M, Chargari C, Bentivegna E, Leary A, et al
    Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
    Anticancer Res. 2019;39:2919-2926.
    Abstract    

    Abstract available

  107. YAO W, Lin Z, Wang G, Li S, et al
    Delicaflavone induces apoptosis via mitochondrial pathway accompanying G2/M cycle arrest and inhibition of MAPK signaling cascades in cervical cancer HeLa cells.
    Phytomedicine. 2019;62:152973.
    Abstract    

    Abstract available

  108. CANFELL K
    Towards the global elimination of cervical cancer.
    Papillomavirus Res. 2019 Jun 6:100170. doi: 10.1016/j.pvr.2019.100170.
    Abstract    

    Abstract available

  109. ZHANG Y, Yan H, Li R, Guo Y, et al
    High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
    Medicine (Baltimore). 2019;98:e15607.
    Abstract    

    Abstract available

  110. LICHTENBERG R
    To the Editor: Human papillomavirus.
    Cleve Clin J Med. 2019;86:300.
    Abstract    



  111. DUSKA LR
    When prospective randomised trials have unexpected results: where do we go from there?
    BJOG. 2019;126:960.
    Abstract    



  112. ZHANG X, Zhi Y, Li Y, Fan T, et al
    Study on the relationship between methylation status of HPV 16 E2 binding sites and cervical lesions.
    Clin Chim Acta. 2019;493:98-103.
    Abstract    

    Abstract available

  113. WADHWANI M, Phuljhele S, Kumar R, Shameer A, et al
    Cervical carcinoma leading to orbital apex syndrome and blindness.
    BMJ Case Rep. 2019;12.
    Abstract    

    Abstract available

  114. KFOURI CFDA, Lombardi W, Romania MCFN, Puls ML, et al
    Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis.
    Rev Col Bras Cir. 2019;46:e2077.
    Abstract    

    Abstract available

  115. CHEN Y, Hou Y, Yang Y, Pan M, et al
    Gene expression changes in cervical squamous cancers following neoadjuvant interventional chemoembolization.
    Clin Chim Acta. 2019;493:79-86.
    Abstract    

    Abstract available

  116. ZHU J, Han S
    miR-150-5p promotes the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via targeting SRCIN1.
    Pathol Res Pract. 2019;215:738-747.
    Abstract    

    Abstract available

  117. NICOL AF, de Andrade CV, Gomes SC Jr, Brusadelli MG, et al
    The distribution of novel biomarkers in carcinoma-in-situ, microinvasive, and squamous cell carcinoma of the uterine cervix.
    Ann Diagn Pathol. 2019;38:115-122.
    Abstract    

    Abstract available

  118. AIJAZ M, Alam K, Maheshwari V, Hakim S, et al
    Clinicopathological study of role of CD34 expressions in the stroma of premalignant and malignant lesions of uterine cervix.
    Ann Diagn Pathol. 2019;38:87-92.
    Abstract    

    Abstract available

  119. KOENEMAN MM, Ovestad IT, Janssen EAM, Ummelen M, et al
    Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
    Pathol Oncol Res. 2019;25:549-557.
    Abstract    

    Abstract available

  120. MALDONADO CASTANEDA OJ
    (Un)contested evidence: scientific literature, systematic reviews and the politics of evidence in the introduction of HPV vaccines in Colombia.
    Sociol Health Illn. 2019;41:81-94.
    Abstract    

    Abstract available

  121. CHEN M, Ai G, Zhou J, Mao W, et al
    circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893.
    Biomed Pharmacother. 2019;117:109064.
    Abstract    

    Abstract available

  122. ZHANG J, Le G, Larochelle D, Pasick R, et al
    Facts or stories? How to use social media for cervical cancer prevention: A multi-method study of the effects of sender type and content type on increased message sharing.
    Prev Med. 2019 Jun 18:105751. doi: 10.1016/j.ypmed.2019.105751.
    Abstract    

    Abstract available

  123. MORGAN EL, Macdonald A
    Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFkappaB-IL-6 signalling axis.
    PLoS Pathog. 2019;15:e1007835.
    Abstract    

    Abstract available

  124. ILISIU MB, Hashim D, Andreassen T, Stoer NC, et al
    HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions.
    Ann Glob Health. 2019;85.
    Abstract    

    Abstract available

  125. WANG Z, Hao M, Yang A, Wang W, et al
    Dietary Mineral Intake Is Associated with the Risk of Cervical Cancer: A Chinese Population-based Study (P05-037-19).
    Curr Dev Nutr. 2019;3.
    Abstract    

    Abstract available

  126. OLUBODUN T, Odukoya OO, Balogun MR
    Knowledge, attitude and practice of cervical cancer prevention, among women residing in an urban slum in Lagos, South West, Nigeria.
    Pan Afr Med J. 2019;32:130.
    Abstract    

    Abstract available

  127. NKFUSAI NC, Cumber SN, Williams T, Anchang-Kimbi JK, et al
    Cervical cancer in the Bamenda Regional Hospital, North West Region of Cameroon: a retrospective study.
    Pan Afr Med J. 2019;32:90.
    Abstract    

    Abstract available

  128. MAO Z, Sang MM, Chen C, Zhu WT, et al
    CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
    Int J Biol Sci. 2019;15:1310-1324.
    Abstract    

    Abstract available

  129. IQBAL J, Ejaz SA, Miliutina M, Langer P, et al
    Anti-proliferative Effects of Chromones: Potent Derivatives Affecting Cell Growth and Apoptosis in Breast, Bone-marrow and Cervical Cancer Cells.
    Med Chem. 2019 Jun 21. pii: MC-EPUB-99163.
    Abstract    

    Abstract available

  130. WANG L, Zhao W, Hong J, Niu F, et al
    Association between IL1B gene and cervical cancer susceptibility in Chinese Uygur Population: A Case-Control study.
    Mol Genet Genomic Med. 2019 Jun 20:e779. doi: 10.1002.
    Abstract    

    Abstract available

  131. LIU Y, Li L, Wu M, Ma S, et al
    The impact of the surgical routes and learning curve of radical hysterectomy on the survival outcomes in stage IB cervical cancer: A retrospective cohort study.
    Int J Surg. 2019 Jun 17. pii: S1743-9191(19)30135.
    Abstract    

    Abstract available

  132. BREWER N, Foliaki S, Bromhead C, Viliamu-Amusia I, et al
    Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Maori and Pasifika women: a pilot study.
    N Z Med J. 2019;132:21-31.
    Abstract    

    Abstract available

  133. ALMEHMADI MM, Salih MM, Al-Hazmi AS
    Awareness of human papillomavirus infection complications, cervical cancer, and vaccine among the Saudi population. A cross-sectional survey.
    Saudi Med J. 2019;40:555-559.
    Abstract    

    Abstract available

  134. FARBOD M, Karimi MZ, Heiranizadeh N, Seifi NS, et al
    Association of TNF-α -308G>A Polymorphism with Susceptibility to Cervical Cancer and Breast Cancer - a Systematic Review and Meta-analysis.
    Klin Onkol. 2019;32:170-180.
    Abstract    

    Abstract available

  135. SHIH CC, Chou HC, Chen YJ, Kuo WH, et al
    Role of PGRMC1 in cell physiology of cervical cancer.
    Life Sci. 2019 Jun 16. pii: S0024-3205(19)30461.
    Abstract    

    Abstract available

  136. TINGTING C, Shizhou Y, Songfa Z, Junfen X, et al
    Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells.
    Cancer Med. 2019 Jun 18. doi: 10.1002/cam4.2351.
    Abstract    

    Abstract available

  137. SARENAC T, Mikov M
    Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease.
    Front Pharmacol. 2019;10:484.
    Abstract    

    Abstract available

  138. YOU KY, Peng HH, Jiang YH, Bi ZF, et al
    Selective use of concurrent chemotherapy in elderly cervical cancer patients treated with definitive radiotherapy: experience from two institutions.
    Cancer Manag Res. 2019;11:4815-4823.
    Abstract    

    Abstract available

  139. PAN D, Zhang CQ, Liang QL, Hong XC, et al
    An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening.
    Cancer Manag Res. 2019;11:4773-4780.
    Abstract    

    Abstract available

  140. FISCHEROVA D, Cibula D
    The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Ceska Gynekol. 2019;84:40-48.
    Abstract    

    Abstract available

  141. SHAO S, Wang C, Wang S, Zhang H, et al
    LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Biomed Pharmacother. 2019;117:109082.
    Abstract    

    Abstract available

  142. KELLY-HANKU A, Newland J, Aggleton P, Ase S, et al
    HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccine.
    Papillomavirus Res. 2019 Jun 15:100171. doi: 10.1016/j.pvr.2019.100171.
    Abstract    



  143. LI YM, Li XJ, Yang HL, Zhang YB, et al
    MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:4688-4697.
    Abstract    

    Abstract available

  144. QU B, Zhao AH, Nie XZ, Sui R, et al
    Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
    Eur Rev Med Pharmacol Sci. 2019;23:4680-4687.
    Abstract    

    Abstract available

  145. ZHANG P, Lu Y, Gao S
    High-mobility group box 2 promoted proliferation of cervical cancer cells by activating AKT signaling pathway.
    J Cell Biochem. 2019 Jun 18. doi: 10.1002/jcb.28998.
    Abstract    

    Abstract available

  146. YANG W, Xu X, Hong L, Wang Q, et al
    Upregulation of lncRNA GAS5 inhibits the growth and metastasis of cervical cancer cells.
    J Cell Physiol. 2019 Jun 17. doi: 10.1002/jcp.28926.
    Abstract    

    Abstract available

  147. WANG MZ, Feng RM, Wang S, Duan XZ, et al
    CLINICAL PERFORMANCE OF HPV TESTING AND VIA IN PRIMARY, COMBINATION, AND SEQUENTIAL CERVICAL CANCER SCREENING IN CHINA.
    Sex Transm Dis. 2019 Jun 14. doi: 10.1097/OLQ.0000000000001026.
    Abstract    

    Abstract available

  148. KALIFF M, Karlsson MG, Sorbe B, Bohr Mordhorst L, et al
    HPV-negative Tumors in a Swedish Cohort of Cervical Cancer.
    Int J Gynecol Pathol. 2019 Jun 14. doi: 10.1097/PGP.0000000000000612.
    Abstract    

    Abstract available

  149. ZHU Y, Zhang GN, Shi Y, Cui L, et al
    Perineural invasion in cervical cancer: pay attention to the indications of nerve-sparing radical hysterectomy.
    Ann Transl Med. 2019;7:203.
    Abstract    

    Abstract available

  150. NIE D, Zheng Q, Liu L, Mao X, et al
    Up-regulated of Angiopoietin-Like Protein 4 Predicts Poor Prognosis in Cervical Cancer.
    J Cancer. 2019;10:1896-1901.
    Abstract    

    Abstract available

  151. OU J, Guan D, Yang Y
    Non-contact co-culture with human vascular endothelial cells promotes epithelial-to-mesenchymal transition of cervical cancer SiHa cells by activating the NOTCH1/LOX/SNAIL pathway.
    Cell Mol Biol Lett. 2019;24:39.
    Abstract    

    Abstract available

  152. LI N, Guo X, Liu L, Wang L, et al
    Molecular mechanism of miR-204 regulates proliferation, apoptosis and autophagy of cervical cancer cells by targeting ATF2.
    Artif Cells Nanomed Biotechnol. 2019;47:2529-2535.
    Abstract    

    Abstract available

  153. HAN M, Sun D
    Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.
    J Comput Aided Mol Des. 2019 Jun 15. pii: 10.1007/s10822-019-00211.
    Abstract    

    Abstract available

  154. LIN YC, Chen RY, Liang JA, Hung YC, et al
    Immunohistochemical Biomarkers of Survival in Patients With Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
    Anticancer Res. 2019;39:3231-3240.
    Abstract    

    Abstract available

  155. CHEN SW, Liang JA, Hung YC, Yeh LS, et al
    Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
    Anticancer Res. 2019;39:3015-3024.
    Abstract    

    Abstract available

  156. CHIEN P
    How should we deal with unexpected results from randomised trials?
    BJOG. 2019;126:949-950.
    Abstract    



  157. LYU YJ, Ding L, Li QL, Li L, et al
    [Effects of hnRNP E1 and both early genes E2 and E6 of HPV16 together with their interactions on cervical carcinogenesis].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40:466-470.
    Abstract    

    Abstract available

  158. BHATTACHARJEE S, Jaiswal RK, Yadava PK
    Measles virus phosphoprotein inhibits apoptosis and enhances clonogenic and migratory properties in HeLa cells.
    J Biosci. 2019;44.
    Abstract    

    Abstract available

  159. MIAO H, Cao B, Ge W, Zhao W, et al
    Expression of p16 and p27 protein in cervical exfoliated cells and its relationship with high risk human papilloma virus in cervical lesions.
    J Biol Regul Homeost Agents. 2019;33:197-203.
    Abstract    



  160. FUENTES-GONZALEZ AM, Munoz-Bello JO, Manzo-Merino J, Contreras-Paredes A, et al
    Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated with apoptosis and cell proliferation.
    Arch Virol. 2019;164:1815-1827.
    Abstract    

    Abstract available

  161. UEDA Y, Yagi A, Ikeda S, Enomoto T, et al
    Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
    Lancet Oncol. 2018;19:1563-1564.
    Abstract    



  162. FRUMOVITZ M, Plante M, Lee PS, Sandadi S, et al
    Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.
    Lancet Oncol. 2018 Aug 21. pii: S1470-2045(18)30448.
    Abstract    

    Abstract available

  163. HASHIGUCHI M, Nakao Y, Honda A, Kawaguchi A, et al
    What Has Changed Since the Introduction of Human Papillomavirus Testing with the Cytology-Based Cervical Cancer Screening System in Japan A Social Experiment.
    Acta Cytol. 2019 Jun 4:1-6. doi: 10.1159/000500190.
    Abstract    

    Abstract available

  164. KARIA N, Van Loon A, Simoens C, Benoy I, et al
    The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic Review.
    Acta Cytol. 2019;63:206-214.
    Abstract    

    Abstract available

  165. NAKAMURA M, Ueda M, Iwata T, Kiguchi K, et al
    A Clinical Trial to Verify the Efficiency of the LC-1000 Exfoliative Cell Analyzer as a New Method of Cervical Cancer Screening.
    Acta Cytol. 2019 Jun 19:1-10. doi: 10.1159/000501118.
    Abstract    

    Abstract available

  166. PLUMMER C, Michael A, Shaikh G, Stewart M, et al
    Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK.
    Br J Cancer. 2019 Jun 11. pii: 10.1038/s41416-019-0481.
    Abstract    

    Abstract available

  167. SERRANO-AREVALO ML, Flores-Hernandez L, Villegas-Gonzalez LF, Zamora-Zarco S, et al
    Cytomorphological features of high-grade intraepithelial neoplasia/carcinoma of the cervix following chemoradiotherapy.
    Diagn Cytopathol. 2019;47:194-199.
    Abstract    

    Abstract available

  168. ALFONZO E, Wallin E, Ekdahl L, Staf C, et al
    No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study.
    Eur J Cancer. 2019;116:169-177.
    Abstract    

    Abstract available

  169. SONG T, Seong SJ, Lee SK, Kim BR, et al
    Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
    Eur J Obstet Gynecol Reprod Biol. 2019;234:112-116.
    Abstract    

    Abstract available

  170. WILLOWS K, Kupets R, Diong C, Vicus D, et al
    Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population based study.
    Gynecol Oncol. 2019 Jun 3. pii: S0090-8258(19)31263.
    Abstract    

    Abstract available

  171. VAN LEEUWEN RW, Ostrbenk A, Poljak M, van der Zee AGJ, et al
    DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    Int J Cancer. 2019;144:746-754.
    Abstract    

    Abstract available

  172. ROHNER E, Butikofer L, Schmidlin K, Sengayi M, et al
    Cervical cancer risk in women living with HIV across four continents: A multicohort study.
    Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32260.
    Abstract    

    Abstract available

  173. OBERLIN AM, Pasipamire T, Chibwesha CJ
    Exploring women's preferences for HPV-based cervical cancer screening in South Africa.
    Int J Gynaecol Obstet. 2019 May 25. doi: 10.1002/ijgo.12869.
    Abstract    

    Abstract available

  174. SONG J, Chen W, Zhu X, Zhao Z, et al
    Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer.
    Int J Gynaecol Obstet. 2019 Jun 17. doi: 10.1002/ijgo.12888.
    Abstract    

    Abstract available

  175. VAN DER VELDEN J, Mom CH, van Lonkhuijzen L, Tjiong MY, et al
    Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy.
    Int J Gynecol Cancer. 2019 May 27. pii: ijgc-2019-000445.
    Abstract    

    Abstract available

  176. UPPAL S, Spencer R
    Modify or abandon: minimally invasive radical hysterectomy for early-stage cervical cancer.
    Int J Gynecol Cancer. 2019;29:843-844.
    Abstract    



  177. FALCONER H, Palsdottir K, Stalberg K, Dahm-Kahler P, et al
    Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial.
    Int J Gynecol Cancer. 2019 Jun 14. pii: ijgc-2019-000558.
    Abstract    

    Abstract available

  178. WAKATSUKI M, Kato S, Ohno T, Banu PA, et al
    Multi-institutional observational study of prophylactic extended-field concurrent chemoradiotherapy using weekly cisplatin for patients with pelvic node-positive cervical cancer in East and Southeast Asia.
    Int J Radiat Oncol Biol Phys. 2019 May 21. pii: S0360-3016(19)30737.
    Abstract    

    Abstract available

  179. MAHANTSHETTY U, Naga Ch P, Khadanga CR, Gudi S, et al
    A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Int J Radiat Oncol Biol Phys. 2018 Jun 7. pii: S0360-3016(18)30933.
    Abstract    

    Abstract available

  180. MATSUO K, Shimada M, Yamaguchi S, Matoda M, et al
    Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer.
    Obstet Gynecol. 2019;133:1086-1098.
    Abstract    

    Abstract available

  181. RAO GG
    Surgical Volume and Survival in Cervical Cancer: Bigger Is Better.
    Obstet Gynecol. 2019;133:1084-1085.
    Abstract    



  182. WRIGHT JD, Matsuo K, Huang Y, Tergas AI, et al
    Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003311.
    Abstract    

    Abstract available

  183. XU R, Chen L, Yang WT
    Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
    Oncol Rep. 2019 Jun 6. doi: 10.3892/or.2019.7188.
    Abstract    

    Abstract available

  184. SONG Q, Yi F, Zhang Y, Jun Li DK, et al
    CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    BMC Cancer. 2019;19:499.
    Abstract    

    Abstract available

  185. MCSHERRY LA, O'Leary E, Dombrowski SU, Francis JJ, et al
    Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives.
    PLoS One. 2018;13:e0208482.
    Abstract    

    Abstract available

  186. VODICKA EL, Chung MH, Zimmermann MR, Kosgei RJ, et al
    Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.
    PLoS One. 2019;14:e0217331.
    Abstract    

    Abstract available

  187. BERGENGREN L, Lillsunde-Larsson G, Helenius G, Karlsson MG, et al
    HPV-based screening for cervical cancer among women 55-59 years of age.
    PLoS One. 2019;14:e0217108.
    Abstract    

    Abstract available

  188. MINNAAR CA, Kotzen JA, Ayeni OA, Naidoo T, et al
    The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial.
    PLoS One. 2019;14:e0217894.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;